Clinical Trials Directory

Trials / Completed

CompletedNCT02157701

Polyherbal Capsule Formulation for Joint Health

Polyherbal Capsule Formulation for Joint Health: a Multicenter, 2-arm, Randomized, Double-blind, Placebo-controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
108 (actual)
Sponsor
NewChapter, Inc. · Industry
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, study in subjects with exercise-related knee pain/discomfort to determine the efficacy of a polyherbal capsule compared to placebo capsule in improving exercise capacity and overall parameters of joint health.

Detailed description

Subjects will come to the study site at Visit 1 for screening assessments (which will occur within 14 days before the start of the run-in period) and to answer questions associated with habitual diet, exercise capacity, and level of activity. Those subjects who meet initial inclusion/exclusion criteria will undergo a run-in period of at least 7 days at home to discontinue use of all concurrent dietary supplements. Subjects will then return to the study site at Visit 2 (Baseline; Day 0) for further assessments and those meeting all inclusion/exclusion criteria will be enrolled into the study and randomly assigned to study product. Approximately 108 subjects (54 per treatment group) will be enrolled in the study. Subjects will be evaluated at Visit 3 (Day 14), Visit 4 (Day 45), Visit 5 (Day 60, phone call), and Visit 6 (Day 90). Exercise capacity (ie, 6-minute timed walk distance test) will be assessed, along with overall knee wellness and joint-related symptoms using WOMAC, PGA, Knee Pain Rating Scale, and rescue medication usage. Safety will be assessed by collecting adverse events (AEs) and clinical laboratory data.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolyherbal capsule
DIETARY_SUPPLEMENTPlacebo capsule

Timeline

Start date
2014-06-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2014-06-06
Last updated
2015-10-14

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02157701. Inclusion in this directory is not an endorsement.